Annual CFF
$151.75 M
+$147.85 M+3784.13%
31 December 2023
Summary:
Acumen Pharmaceuticals annual cash flow from financing activities is currently $151.75 million, with the most recent change of +$147.85 million (+3784.13%) on 31 December 2023. During the last 3 years, it has risen by +$107.08 million (+239.68%). ABOS annual CFF is now -24.30% below its all-time high of $200.47 million, reached on 31 December 2021.ABOS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$42.00 K
+$86.00 K+67.19%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly cash flow from financing activities is currently -$42.00 thousand, with the most recent change of +$86.00 thousand (+67.19%) on 30 September 2024. Over the past year, it has dropped by -$122.81 million (-100.03%). ABOS quarterly CFF is now -100.02% below its all-time high of $168.78 million, reached on 30 September 2021.ABOS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$36.07 M
-$122.81 M-77.30%
30 September 2024
Summary:
Acumen Pharmaceuticals TTM cash flow from financing activities is currently $36.07 million, with the most recent change of -$122.81 million (-77.30%) on 30 September 2024. Over the past year, it has dropped by -$90.73 million (-71.55%). ABOS TTM CFF is now -85.29% below its all-time high of $245.13 million, reached on 30 September 2021.ABOS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3784.1% | -100.0% | -71.5% |
| 3 y3 years | +239.7% | -100.0% | -85.3% |
| 5 y5 years | - | - | - |
ABOS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -24.3% | +3784.1% | -100.0% | +84.0% | -85.3% | >+9999.0% |
| 5 y | 5 years | -24.3% | +3784.1% | -100.0% | +84.0% | -85.3% | >+9999.0% |
| alltime | all time | -24.3% | +3784.1% | -100.0% | +84.0% | -85.3% | >+9999.0% |
Acumen Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$42.00 K(-67.2%) | $36.07 M(-77.3%) |
| June 2024 | - | -$128.00 K(-101.8%) | $158.88 M(+0.0%) |
| Mar 2024 | - | $7.11 M(-75.6%) | $158.86 M(+4.7%) |
| Dec 2023 | $151.75 M(+3784.1%) | $29.13 M(-76.3%) | $151.75 M(+19.7%) |
| Sept 2023 | - | $122.76 M(<-9900.0%) | $126.80 M(+3258.1%) |
| June 2023 | - | -$145.00 K(<-9900.0%) | $3.78 M(-3.4%) |
| Mar 2023 | - | $0.00(-100.0%) | $3.91 M(0.0%) |
| Dec 2022 | $3.91 M | $4.18 M(-1690.9%) | $3.91 M(-1563.3%) |
| Sept 2022 | - | -$263.00 K(+1778.6%) | -$267.00 K(-100.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$14.00 K(-240.0%) | $168.78 M(-15.8%) |
| Dec 2021 | $200.47 M(+348.7%) | $10.00 K(-100.0%) | $200.47 M(-18.2%) |
| Sept 2021 | - | $168.78 M(+432.9%) | $245.13 M(+221.1%) |
| June 2021 | - | $31.68 M(-29.1%) | $76.35 M(+70.9%) |
| Dec 2020 | $44.67 M(+616.1%) | - | - |
| Dec 2020 | - | $44.67 M(>+9900.0%) | $44.67 M(>+9900.0%) |
| Sept 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $6.24 M | - | - |
FAQ
- What is Acumen Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual CFF year-on-year change?
- What is Acumen Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly CFF year-on-year change?
- What is Acumen Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals TTM CFF year-on-year change?
What is Acumen Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ABOS is $151.75 M
What is the all time high annual CFF for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual cash flow from financing activities is $200.47 M
What is Acumen Pharmaceuticals annual CFF year-on-year change?
Over the past year, ABOS annual cash flow from financing activities has changed by +$147.85 M (+3784.13%)
What is Acumen Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of ABOS is -$42.00 K
What is the all time high quarterly CFF for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly cash flow from financing activities is $168.78 M
What is Acumen Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, ABOS quarterly cash flow from financing activities has changed by -$122.81 M (-100.03%)
What is Acumen Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of ABOS is $36.07 M
What is the all time high TTM CFF for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high TTM cash flow from financing activities is $245.13 M
What is Acumen Pharmaceuticals TTM CFF year-on-year change?
Over the past year, ABOS TTM cash flow from financing activities has changed by -$90.73 M (-71.55%)